EDP-305, a novel and highly potent farnesoid X receptor agonist, improves liver steatosis, ballooning and non-alcoholic fatty liver disease (NAFLD) activity score (NAS) in a diet-induced murine model of non-alcoholic steatohepatitis

被引：1
|
作者：
Jiang, L. -J. [1 ]
Chau, M. [1 ]
Li, Y. [1 ]
Briand, F. [2 ]
Sulpice, T. [2 ]
Or, Y. S. [1 ]
机构：
[1] Enanta Pharmaceut Inc, Watertown, MA USA
[2] Physiogenex, Labege, France
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)31237-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-363
引用
收藏
页码：S434 / S434
页数：1
相关论文
共 50 条
  • [21] Comparison of Non-Alcoholic Fatty Liver Disease (NAFLD) Model using Diet-Induced NAFLD Mice with Modified Mice
    Goon, Mohd Danial Mohd efendy
    Rahim, Sharaniza ab
    Latip, Normala abd
    Aziz, Mardiana Abdul
    Noor, Norizal Mohd
    Weih, Lew Sook
    Mazlan, Musalmah
    Abdul Kadir, Siti Hamimah Sheikh
    SAINS MALAYSIANA, 2022, 51 (06): : 1821 - 1832
  • [22] A Comparison of Brunt's Criteria, the Non-Alcoholic Fatty Liver Disease Activity Score (NAS), and a Proposed NAS Scoring that Includes Fibrosis in Non-Alcoholic Fatty Liver Disease Staging
    Santiago-Rolon, Amarilys
    Purcell, Dagmary
    Rosado, Kathia
    Toro, Doris H.
    PUERTO RICO HEALTH SCIENCES JOURNAL, 2015, 34 (04) : 189 - 194
  • [23] Hepatoprotective effects of gemigliptin and empagliflozin in a murine model of diet-induced non-alcoholic fatty liver disease
    Lee, Nami
    Heo, Yu Jung
    Choi, Sung-E
    Jeon, Ja Young
    Han, Seung Jin
    Kim, Dae Jung
    Kang, Yup
    Lee, Kwan Woo
    Kim, Hae Jin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 588 : 154 - 160
  • [24] A diet-induced murine model for non-alcoholic fatty liver disease with obesity and insulin resistance that rapidly develops steatohepatitis and fibrosis
    Sakuma, Takafumi
    Nakamura, Masato
    Chiba, Tetsuhiro
    Iwanaga, Terunao
    Kan, Motoyasu
    Kojima, Ryuta
    Ao, Junjie
    Ma, Yaojia
    Unozawa, Hidemi
    Fujita, Naoto
    Kanayama, Kengo
    Kanzaki, Hiroaki
    Koroki, Keisuke
    Kobayashi, Kazufumi
    Nakagawa, Ryo
    Kanogawa, Naoya
    Kiyono, Soichiro
    Kondo, Takayuki
    Saito, Tomoko
    Ogasawara, Sadahisa
    Nakamoto, Shingo
    Muroyama, Ryosuke
    Kato, Jun
    Kishimoto, Takashi
    Kato, Naoya
    LABORATORY INVESTIGATION, 2022, 102 (10) : 1150 - 1157
  • [25] A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer
    Asgharpour, Amon
    Cazanave, Sophie C.
    Pacana, Tommy
    Seneshaw, Mulugeta
    Vincent, Robert
    Banini, Bubu A.
    Kumar, Divya Prasanna
    Daita, Kalyani
    Min, Hae-Ki
    Mirshahi, Faridoddin
    Bedossa, Pierre
    Sun, Xiaochen
    Hoshida, Yujin
    Koduru, Srinivas V.
    Contaifer, Daniel, Jr.
    Warncke, Osinska
    Wijesinghe, Dayanjan S.
    Sanyal, Arun J.
    JOURNAL OF HEPATOLOGY, 2016, 65 (03) : 579 - 588
  • [26] Alterations to the mitochondrial proteome in a diet-induced model of non-alcoholic fatty liver disease
    Eccleston, Heather B.
    Andringa, Kelly K.
    Mantena, Sudheer K.
    Bailey, Shannon M.
    FREE RADICAL BIOLOGY AND MEDICINE, 2007, 43 : S76 - S76
  • [27] Sevelamer improves hepatic steatosis and modulates inflammation in a Western Diet mouse model of non-alcoholic fatty liver disease (NAFLD)
    McGettigan, Brett
    McMahan, Rachel
    Porsche, Cara
    Orlicky, David J.
    Wang, Xiaoxin
    Luo, Yuhuan
    Levi, Moshe
    Rosen, Hugo R.
    HEPATOLOGY, 2014, 60 : 746A - 747A
  • [28] Validity of the Non-Alcoholic Fatty Liver Disease Activity Score (NAS): Comparing the Nas With Pathology Diagnosis
    Hjelkrem, Michael
    Stauch, Chris
    Harrison, Stephen
    Shaw, Janet
    GASTROENTEROLOGY, 2011, 140 (05) : S988 - S988
  • [29] Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice
    Wu, Jingyi
    Jia, Shu
    Xu, Benghong
    Yao, Xiaokun
    Shao, Jingping
    Yao, Jianzuo
    Cen, Danwei
    Yao, Xiaomin
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [30] Mediterranean diet as the ideal model for preventing non-alcoholic fatty liver disease (NAFLD)
    Martinez-Gonzalez, Miguel A.
    Bastarrika, Gorka
    HEPATOBILIARY SURGERY AND NUTRITION, 2020, 9 (03) : 379 - 381
12345